The Department's Annual Report for the academic year 2019-2020 has been released. The brochure showcases a selection of the year's highlights; from a cross-section of our cutting-edge research, to notable events hosting distinguished international scholars, to our response to the COVID-19 pandemic.
DPAG is among the departments receiving funding from the University's research response fund to undertake COVID-19 research. As part of this effort, the Swietach lab has been studying oxygen transport in the blood of COVID-19 patients. The first results of this study are now published in the British Journal of Haematology and could pave the way for new guidelines for treating the virus.
Researchers from DPAG and the Department of Psychiatry, including Dr Nikita Ved, in collaboration with The India League, are calling British Indians to voice their opinions and be a part of a seminal piece of work.
Associate Professor Vladyslav Vyazovskiy has edited a special issue of Current Opinion of Physiology with Professor A. Jennifer Morton from the University of Cambridge. \u201cPhysiology of Sleep\u201d compiles the latest developments in sleep research around the complex question of \u2018why do we sleep?\u2019
A key hormone in the fetal liver has been found for the first time to play a critical role in determining iron endowment in the newborn baby. Up until now, widely held notions made in comparison to how the adult liver controls iron in the body have led to a common focus on how maternal iron status and function of the placenta determines a baby's iron status. A new study from the Lakhal-Littleton group reveals a more autonomous process takes place within the fetus than previously understood.
Dr Kerry Walker is University Research Lecturer and principal investigator of the Walker group, a research team investigating how the activity of neurons in the brain gives rise to our perception of sound.
The annual Prize Lecture from The Physiological Society will provide an opportunity to highlight the importance of the Lakhal-Littleton lab's work into iron control in systems physiology.
Congratulations are in order for DPhil student Oliver Neely of the Paterson and Domingos labs, who has been awarded the Peter Beaconsfield Prize in Physiological Sciences 2020.
The destruction of red blood cells known as hemolysis in the newborn baby is very dangerous, but existing clinical methods are not sufficient for rapid diagnosis and can lead to delays early-life care. A new Swietach Group paper has identified a biomarker that could significantly speed up the process.
Dr Stone has been awarded a Wellcome Trust Henry Dale Fellowship to lead research investigating how lineage history can impact vascular cell fate and function.
Researchers at the University of Oxford led by DPAG's Professor Peter Robbins are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
DPAG researchers have collaborated on an international study that demonstrates a detailed mechanistic understanding of how the anti-malaria drug, Hydroxychloroquine, combined with antibiotics, can cause adverse cardiac side-effects in COVID-19 patients. This gives weight to US Federal advice against using this combined treatment.
The collaborating groups of Professor Stephen Goodwin and Professor Scott Waddell based in The Centre for Neural Circuits and Behaviour (CNCB) are shedding new light on what precisely constitutes a neuronal cell type.
Professor Gero Miesenb\u00f6ck, the Waynflete Professor of Physiology and Director of the Centre for Neural Circuits and Behaviour, is one of three scientists awarded The Shaw Prize in Life Science and Medicine.
A collaborative research team from the Universities of Oxford and Cambridge co-led by DPAG's Associate Professor Ana Domingos have developed a new weight-loss amphetamine that could potentially avoid the harmful side effects of traditional treatments.
Wade-Martins Lab members took part in the 2.6 challenge to raise vital funds for Parkinson's UK. Challenges included running for 2.6 miles, baking 26 cookies, 260 sit ups and 2600 steps.
DPAG's Associate Professor Mathilda Mommersteeg and Professor Paul Riley, in collaboration with Professor Robin Choudhury from the Radcliffe Department of Medicine, will perform single cell analysis of inflammation during heart regeneration with a grant from the Chan Zuckerberg Initiative.
![\"Annual](\"https://www.dpag.ox.ac.uk/news/annual-report-2019-2020/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n